Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study-Reference-Cited by-同舟云学术

Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study

Published:2023 Issue: Volume:98 Page:100689
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Pham Alex T.^ORCID,Bradley Chris^ORCID,Casey Corinne^ORCID,Jampel Henry D.,Ramulu Pradeep Y.,Yohannan Jithin^ORCID

Funder

National Institutes of Health

Research to Prevent Blindness

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference27 articles.

1. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;British Journal of Ophthalmology,2006

2. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial;Heijl;Arch Ophthalmol,2002

3. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators;Am J Ophthalmol,2000

4. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery;Lichter;Ophthalmology,2001

5. Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Reporting Electronic Health Record Data in Glaucoma;Ophthalmology Glaucoma;2024-04

2. Rho Kinase Inhibitors: Strategies in Glaucoma Treatment in Older Adults;Drugs & Aging;2024-02-28

3. Advantages and disadvantages of using Rho kinase inhibitors to reduce intraocular pressure;Expert Review of Ophthalmology;2024-02-12

4. Side effects of drugs used in ocular treatment;Side Effects of Drugs Annual;2023